I'm in a similar situation (mPSPC) and been on a different ADT (Firmagon first, now Orgolyx), and it's kept my PSA below 0.01 for 2½ years. I'm using it in combination with Erleada, an androgen-reception inhibitor. Given how well I'm responding, my onco team has started talking about many years, up from the original forecast of 5–7.

With these new treatments, everything's in flux.